Thoracic Aortic AneurysmNCT05137366
Transthoracic Ultrasound Evaluation of Thoracic Aortic Aneurysms
An observational study of Thoracic Aortic Aneurysm, run by University Hospital Southampton NHS Foundation Trust at 1 site in United Kingdom.
Trial summary
The Diagnosis of a thoracic Aortic Aneruysms usually made when imaging an abdominal aortic aneurysm which has reached threshold or as an incidental finding during a chest scan by computed tomography (CT) or magnetic resonance imaging (MRI). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Thoracic Aortic Aneurysm
- What is being tested?
- Transthoracic ultrasound scan
- How many people
- 40 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 11 Apr 2021to Aug 2023
- How long will I take part?
- 1 Month
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: All patients recruited will be under the care of the Wessex vascular network at Southampton General Hospital. All patients will be identified using a key work search on CT scans from the last 5 years. This will be carried out by a member of the radiology research team at Southampton General Hospital. Participants who would be eligible for the TAA group would be identified by completing a keyword search of reports on the radiology information system (CRIS). The search will look for any CT scans with the following key words: * Thoracic aorta * Thoracic aortic aneurysm * TAAA * TEVAR * Ectatic Thoracic Aorta Participants who would be eligible for the AAA group with no known TAA would also be identified by completing a keyword search of reports on CRIS. The search will look for any CT scans with the following key words: * Abdominal aorta * Abdominal aortic aneurysm * AAA * EVAR * Ectatic abdominal Aorta
Who may be able to join
- For both the Thoracic Aortic Aneurysm (TAA) group and control group, there are no exclusion criteria for gender, ethnicity or socioeconomic status. However, all patients must have a minimum age of 18 years. Patients must have a diagnosis of a Thoracic Aortic Aneurysm or/and Abdominal aortic aneurysm (AAA)
- The Thoracic Aortic Aneurysm groups will have:
- A medical confirmed TAA defined as an aneurysm measuring >3cm in the thoracic aorta e.g. aortic arch, ascending aorta or descending thoracic aorta.
- Patients may also have a AAA
- Patients may have had a TEVAR and will have a residual sac
- A CT scan of the aorta in the last 3 years
- The Abdominal aortic aneurysm A medically diagnosed Abdominal aortic aneurysm with a CT scan showing no TAA in the last three years. Patients who have also had their AAA repaired will also be eligible for this group.
Who cannot join
- • No diagnosed TAA or AAA
- No CT scan of aorta in last 3 years
- Under 18 years old
- Patient who are unable to consent
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site, 1 recruiting
- Recruiting
Southampton General Hospital
Southampton, SO16 6YD
Hannah Davey, MSc, hannah.davey@uhs.nhs.uk
About this study
The Diagnosis of a thoracic Aortic Aneruysms usually made when imaging an abdominal aortic aneurysm which has reached threshold or as an incidental finding during a chest scan by computed tomography (CT) or magnetic resonance imaging (MRI). However, these imaging modalities are expensive, involve radiation exposure and can cause anaphylaxis and other allergic reaction from the contract agents used. In addition CT scans are contraindicated for those who have: allergic reactions to the contrast, radioactive iodine treatment for thyroid disease, metformin use, and chronic or acutely worsening renal disease.
Ultrasound is a non-invasive imaging modality that is cheaper than the methods currently used for TAA detection and surveillance. Echocardiography is limited in assessing the TAA as it is not sensitive to image beyond the proximal ascending aorta which is why it is currently not used for screening or surveillance.
Read more
A pilot study found that ultrasound has the potential to be used as a diagnostic modality for thoracic aortic aneurysms and may have a role in surveillance in patients for whom CT scanning is contraindicated. They found that the sensitivity and specificity of detecting TAA was 100% and 70% for a threshold of 35 mm, and 84% and 90% for a threshold of 40 mm. However, further validation of this methodology is required for it to be considered as a method of diagnosis and surveillance for this patient group. This study was only carried out by one experienced sonographer so it important to repeat this study to see if other sonographers are able to obtain the necessary views.
The main purpose of this study is to validate the protocol used by pilot study to assess whether thoracic aortic aneurysms can be detected and measured accurately using ultrasound.
There are two main objectives of this study:
- Can ultrasound be used to detect thoracic aortic aneurysms?
- Can ultrasound be used to accurately measure thoracic aortic aneurysms?
If the results of this study show that ultrasound has high sensitivity and specificity for detecting thoracic aortic aneurysms, it could lead to a thoracic aorta screening programme.
Read the detailed description
It is important to state that patients involved in this study will not have any changes made to their routine care as a result of this study. All patients recruited would have had a recent CT scan which will be used for the comparison and will not be exposed to any additional radiation as part of the study. The CT scan used will be from the last 3 years so no new diagnoses are expected as a result of the study.
Patients There will be two different groups recruited for this study; Group 1- patients with known thoracic aortic aneurysm (TAA) and Group 2- patients with known abdominal aortic aneurysm (AAA) but no thoracic aortic aneurysm. The known TAA group will be obtained from those who are currently having CT surveillance for either a known TAA or TEVAR (Thoracic Endovascular Repair). The known AAA but no TAA will be obtained from patients who are either under for CT surveillance AAA or EVAR (Endovascular Aneurysm Repair). All patients recruited for this study will be under CT surveillance at Southampton General Hospital or Queen Alexandra hospital and would have had a CT scan within the last 3 years at University Hospital Southampton so no new findings would be expected to come from the study. In addition, the CT scan used will be part of their routine care and there will be no change to their routine care or surveillance as a result of this study.
Both Males and Female participants will be recruited for the study and there will also be a minimum age of 18 as gender will not influence the results of the study.
Participant Recruitment Any patients eligible for the study will be contacted to see if they are interested in taking part and given a participant information sheet. The participant information sheet (PIS) will entail the full details of the study and what it will involve for the patient.
If a patient is interested in participating in the study, a telephone call appointment will be arranged between a member of the research team and the patient. This phone call will involve going through the PIS, answering any questions, and obtaining verbal informed consent. During this appointment, an ultrasound scan appointment will also be arranged.
A referral for the scan will be placed by Ben Patterson using the hospitals e-quest system under the patients hospital number so that images can be stored and a report can be generated and recorded for the patients record. The referral will placed using the code UAOTD and when the referral is on the CRIS system, one of the researchers will insure that the patient is changed to a research scan to ensure that it does not interfere with routine care.
At the ultrasound assessment, written informed consent will be obtained prior to the scan being carried out and there will also be another opportunity for patients to ask any questions. If patients' are unable to consent to the study themselves as they are deemed to have a lack of capacity, they will not be included within the research study and will continue with their routine care.
Collection of demographic data Patients age and gender will be recorded for the study. No other demographic information will be recorded.
Ultrasound scan protocol A single vascular sonographer (Hannah Davey) will complete all ultrasound scans for this study and will be blinded to the CT diagnosis, location, and extent of the aortic pathology in all patients. This will be achieved by a member of the research team arranging the patients' appointment and having a study participant code for the scan referral so that the different groups cannot be identified. The vascular sonographer will also not complete any of the consenting in order to ensure they are blinded to any patient identifiable information.
The maximum diameter (inner wall to inner wall) of the different areas of the thoracic aorta will be measured; primarily focusing on the descending thoracic aorta from the isthmus to the level of the diaphragm will be obtained and recorded for the study. The sensitivity and specificity of detecting TAA will be test at measurements of both 35mm and 40mm
All scans of the thoracic aorta will be performed using a Philips Epiq 5 or Epiq 7 machine with 2 MHz phased array transducer. The patient will lay supine on an ultrasound scan couch which can be tilted in order to optimise the patient position and views required for the scan. The measurements will be taken in B-mode but colour Doppler imaging may be used to identify the thoracic aorta if it is obscured by artefacts. The measurement will be taken inner wall to inner wall and several images will be taken to check reliability.
Three different acoustic windows will be used to image the thoracic aorta:
- Suprasternal window- To visualise aortic arch and the three major supra-aortic vessels
- Parasternal long axis window- To visualise the mid descending thoracic aorta
- Apical two chamber views- To visualise the distal end of the thoracic aorta and proximal segment of the abdominal aorta Ultrasound assessment will be considered satisfactory when at least two of the three regions of the descending thoracic aorta were visualised, partially satisfactory when a single view was obtained and inconclusive when none of the three windows could be obtained The ultrasound scan appointment is estimated to take approximately 30 mins for obtaining written informed consent and completing the scan. All images and measurements taken during the scan will be stored on PACS and a report for the scan will be written on CRIS.
CT Scan protocol
A consultant vascular surgeon (Mr B Patterson) at Southampton General Hospital will review the CT scans and measure the maximum diameter (inner wall to inner wall) of the thoracic aorta. He is highly experienced in imaging patients with thoracic aortic pathology so the measurements will be reliable and valid. All CT scan measurements will be carried out on the picture archiving systems (PACS) at Southampton General Hospital and will also be compared to the measurement reported on system. Similarly to the ultrasound protocol, the maximum diameter of the different areas of the thoracic aorta will be obtained and recorded for the study. The diameter used for the study will be measured inner wall to inner wall in order to allow for comparison and accuracy to the ultrasound scan.
The CT scan used for the measurement will be taken from the most recent aorta scan on the CRIS and PACS systems at Southampton General Hospital or Queen Alexandra Hospital. Patients will not be having any additional scans as part of this study and measurements will only be used from scans as part of their routine care. This is in order to minimise the amount of radiation each patient is exposed too and to make sure that their routine care is not interrupted by them participating in this study.
Images from both the ultrasound scan and CT scan will be stored on a Picture archiving and communication system (PACS). Measurements of the maximum diameter for the ultrasound scan will be completed at the time scan and will be done using the measurement software in the ultrasound machine. The CT scan measurements will be carried out on the PACS system and will be compared to the value reported in the original report to check the accuracy.
Measurements from both the ultrasound and CT scan will be recorded on Microsoft Excel. For each group, mean and standard deviation will be calculated. The sensitivity and specificity of the ultrasound scan will be analysed using cut-off points of both 35mm and 40mm. This will be done using the CT scan measurement as a reference for comparing the accuracy of the ultrasound measurement. Statistical analysis will be carried out on Statistical Package for the Social Sciences (SPSS).
In order to calculate the sensitivity and specificity of ultrasound, a Clopper-Pearson confidence interval will be carried out on Statistical Package for the Social Sciences (SPSS). The statistical analysis will be completed with a 95% confidence interval and will be calculated at both 35mm and 40mm cut-offs.
- Conditions
- Thoracic Aortic Aneurysm
- Being tested
- Transthoracic ultrasound scan
- Medical subject headings
- Aortic Aneurysm, Thoracic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transthoracic ultrasound scanDiagnostic test
An ultrasound scan of the thoracic aorta will be performed using an ultrasound machine with 2 MHz phased array transducer. The patient will lay supine on an ultrasound scan couch.The measurements will be taken in B-mode but colour Doppler imaging may be used to identify the thoracic aorta if it is obscured by artefacts. The measurement will be taken inner wall to inner wall and several images will be taken to check reliability.
Three different acoustic windows will be used to image the thoracic aorta:
- Suprasternal window
- Parasternal long axis window
- Apical two chamber views
Ultrasound assessment will be considered satisfactory when at least two of the three regions of the descending thoracic aorta were visualised, partially satisfactory when a single view was obtained and inconclusive when none of the three windows could be obtained.
| Study group | Role | What they receive |
|---|---|---|
| Known Thoracic aortic aneurysm (TAA) | * A medical confirmed TAA defined as an aneurysm measuring >3cm in the thoracic aorta e.g. aortic arch, ascending aorta or descending thoracic aorta.
* Patients may also have a AAA
* Patients may have had a TEVAR and will have a residual sac
* A CT scan of the aorta in the last 3 years Receives: Diagnostic Test: Transthoracic ultrasound scan | |
| Control group | A medically diagnosed Abdominal aortic aneurysm with a CT scan showing no TAA in the last three years. Patients who have also had their AAA repaired will also be eligible for this group. Receives: Diagnostic Test: Transthoracic ultrasound scan |
What is being measured
The primary outcome is the main question the study is designed to answer.
Can ultrasound detect thoracic aortic aneurysms
Specificity and sensitivity of ultrasound in detecting thoracic aortic aneurysms
Measured: 6 months
Can thoracic aortic aneurysms be accurately measured using ultrasound
Specificity and sensitivity of ultrasound in measuring thoracic aortic aneurysms
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Nov 2021
- Study start11 Apr 2021
- Primary completionJul 2023 (estimated)
- Study completionAug 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Thoracic Aortic AneurysmStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 40 participants (estimated)
- Target duration
- 1 Month
Sponsor and investigators
- Lead sponsor
- University Hospital Southampton NHS Foundation Trust
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Ben Patterson, Principal investigator, University Hospital Southampton NHS Foundation Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05137366
- Sponsor's protocol ID
- RHMCAR0603
- Status last verified
- Apr 2023
- First submitted
- 16 Nov 2021
- Last updated
- 13 Apr 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Access to the final study database will on be allowed for the main researchers of the study and the co-investigators listed on the participant information sheet. The data will be stored on a secure radiology drive on the trust computer system. Archiving will be authorised by the Sponsor following submission of the end of study report. Location and duration of record retention for: * Essential documents: Patient case notes will be stored and maintained according to standard rules and procedures. Pathology results are stored and maintained according to standard procedures. * Study data will be held for minimum of 5 years
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Transthoracic Ultrasound Evaluation of Thoracic Aortic Aneurysms
- ClinicalTrials.gov ID
- NCT05137366
- Acronym / sponsor ID
- RHMCAR0603
- Conditions
- Thoracic Aortic Aneurysm
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- University Hospital Southampton NHS Foundation TrustUniversity, hospital or other
- Study start
- 11 Apr 2021 (actual)
- Primary completion
- Jul 2023 (estimated)
- Study completion
- Aug 2023 (estimated)
- First posted
- 30 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Diagnosis of a thoracic Aortic Aneruysms usually made when imaging an abdominal aortic aneurysm which has reached threshold or as an incidental finding during a chest scan by computed tomography (CT) or magnetic resonance imaging (MRI). However, these imaging modalities are expensive, involve radiation exposure and can cause anaphylaxis and other allergic reaction from the contract agents used. In addition CT scans are contraindicated for those who have: allergic reactions to the contrast, radioactive iodine treatment for thyroid disease, metformin use, and chronic or acutely worsening renal disease.
Ultrasound is a non-invasive imaging modality that is cheaper than the methods currently used for TAA detection and surveillance. Echocardiography is limited in assessing the TAA as it is not sensitive to image beyond the proximal ascending aorta which is why it is currently not used for screening or surveillance.
A pilot study found that ultrasound has the potential to be used as a diagnostic modality for thoracic aortic aneurysms and may have a role in surveillance in patients for whom CT scanning is contraindicated. They found that the sensitivity and specificity of detecting TAA was 100% and 70% for a threshold of 35 mm, and 84% and 90% for a threshold of 40 mm. However, further validation of this methodology is required for it to be considered as a method of diagnosis and surveillance for this patient group. This study was only carried out by one experienced sonographer so it important to repeat this study to see if other sonographers are able to obtain the necessary views.
The main purpose of this study is to validate the protocol used by pilot study to assess whether thoracic aortic aneurysms can be detected and measured accurately using ultrasound.
There are two main objectives of this study:
- Can ultrasound be used to detect thoracic aortic aneurysms?
- Can ultrasound be used to accurately measure thoracic aortic aneurysms?
If the results of this study show that ultrasound has high sensitivity and specificity for detecting thoracic aortic aneurysms, it could lead to a thoracic aorta screening programme.
Detailed description
It is important to state that patients involved in this study will not have any changes made to their routine care as a result of this study. All patients recruited would have had a recent CT scan which will be used for the comparison and will not be exposed to any additional radiation as part of the study. The CT scan used will be from the last 3 years so no new diagnoses are expected as a result of the study.
Patients There will be two different groups recruited for this study; Group 1- patients with known thoracic aortic aneurysm (TAA) and Group 2- patients with known abdominal aortic aneurysm (AAA) but no thoracic aortic aneurysm. The known TAA group will be obtained from those who are currently having CT surveillance for either a known TAA or TEVAR (Thoracic Endovascular Repair). The known AAA but no TAA will be obtained from patients who are either under for CT surveillance AAA or EVAR (Endovascular Aneurysm Repair). All patients recruited for this study will be under CT surveillance at Southampton General Hospital or Queen Alexandra hospital and would have had a CT scan within the last 3 years at University Hospital Southampton so no new findings would be expected to come from the study. In addition, the CT scan used will be part of their routine care and there will be no change to their routine care or surveillance as a result of this study.
Both Males and Female participants will be recruited for the study and there will also be a minimum age of 18 as gender will not influence the results of the study.
Participant Recruitment Any patients eligible for the study will be contacted to see if they are interested in taking part and given a participant information sheet. The participant information sheet (PIS) will entail the full details of the study and what it will involve for the patient.
If a patient is interested in participating in the study, a telephone call appointment will be arranged between a member of the research team and the patient. This phone call will involve going through the PIS, answering any questions, and obtaining verbal informed consent. During this appointment, an ultrasound scan appointment will also be arranged.
A referral for the scan will be placed by Ben Patterson using the hospitals e-quest system under the patients hospital number so that images can be stored and a report can be generated and recorded for the patients record. The referral will placed using the code UAOTD and when the referral is on the CRIS system, one of the researchers will insure that the patient is changed to a research scan to ensure that it does not interfere with routine care.
At the ultrasound assessment, written informed consent will be obtained prior to the scan being carried out and there will also be another opportunity for patients to ask any questions. If patients' are unable to consent to the study themselves as they are deemed to have a lack of capacity, they will not be included within the research study and will continue with their routine care.
Collection of demographic data Patients age and gender will be recorded for the study. No other demographic information will be recorded.
Ultrasound scan protocol A single vascular sonographer (Hannah Davey) will complete all ultrasound scans for this study and will be blinded to the CT diagnosis, location, and extent of the aortic pathology in all patients. This will be achieved by a member of the research team arranging the patients' appointment and having a study participant code for the scan referral so that the different groups cannot be identified. The vascular sonographer will also not complete any of the consenting in order to ensure they are blinded to any patient identifiable information.
The maximum diameter (inner wall to inner wall) of the different areas of the thoracic aorta will be measured; primarily focusing on the descending thoracic aorta from the isthmus to the level of the diaphragm will be obtained and recorded for the study. The sensitivity and specificity of detecting TAA will be test at measurements of both 35mm and 40mm
All scans of the thoracic aorta will be performed using a Philips Epiq 5 or Epiq 7 machine with 2 MHz phased array transducer. The patient will lay supine on an ultrasound scan couch which can be tilted in order to optimise the patient position and views required for the scan. The measurements will be taken in B-mode but colour Doppler imaging may be used to identify the thoracic aorta if it is obscured by artefacts. The measurement will be taken inner wall to inner wall and several images will be taken to check reliability.
Three different acoustic windows will be used to image the thoracic aorta:
- Suprasternal window- To visualise aortic arch and the three major supra-aortic vessels
- Parasternal long axis window- To visualise the mid descending thoracic aorta
- Apical two chamber views- To visualise the distal end of the thoracic aorta and proximal segment of the abdominal aorta Ultrasound assessment will be considered satisfactory when at least two of the three regions of the descending thoracic aorta were visualised, partially satisfactory when a single view was obtained and inconclusive when none of the three windows could be obtained The ultrasound scan appointment is estimated to take approximately 30 mins for obtaining written informed consent and completing the scan. All images and measurements taken during the scan will be stored on PACS and a report for the scan will be written on CRIS.
CT Scan protocol
A consultant vascular surgeon (Mr B Patterson) at Southampton General Hospital will review the CT scans and measure the maximum diameter (inner wall to inner wall) of the thoracic aorta. He is highly experienced in imaging patients with thoracic aortic pathology so the measurements will be reliable and valid. All CT scan measurements will be carried out on the picture archiving systems (PACS) at Southampton General Hospital and will also be compared to the measurement reported on system. Similarly to the ultrasound protocol, the maximum diameter of the different areas of the thoracic aorta will be obtained and recorded for the study. The diameter used for the study will be measured inner wall to inner wall in order to allow for comparison and accuracy to the ultrasound scan.
The CT scan used for the measurement will be taken from the most recent aorta scan on the CRIS and PACS systems at Southampton General Hospital or Queen Alexandra Hospital. Patients will not be having any additional scans as part of this study and measurements will only be used from scans as part of their routine care. This is in order to minimise the amount of radiation each patient is exposed too and to make sure that their routine care is not interrupted by them participating in this study.
Images from both the ultrasound scan and CT scan will be stored on a Picture archiving and communication system (PACS). Measurements of the maximum diameter for the ultrasound scan will be completed at the time scan and will be done using the measurement software in the ultrasound machine. The CT scan measurements will be carried out on the PACS system and will be compared to the value reported in the original report to check the accuracy.
Measurements from both the ultrasound and CT scan will be recorded on Microsoft Excel. For each group, mean and standard deviation will be calculated. The sensitivity and specificity of the ultrasound scan will be analysed using cut-off points of both 35mm and 40mm. This will be done using the CT scan measurement as a reference for comparing the accuracy of the ultrasound measurement. Statistical analysis will be carried out on Statistical Package for the Social Sciences (SPSS).
In order to calculate the sensitivity and specificity of ultrasound, a Clopper-Pearson confidence interval will be carried out on Statistical Package for the Social Sciences (SPSS). The statistical analysis will be completed with a 95% confidence interval and will be calculated at both 35mm and 40mm cut-offs.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Target follow-up
- 1 Month
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Known Thoracic aortic aneurysm (TAA) | – | Diagnostic Test: Transthoracic ultrasound scan* A medical confirmed TAA defined as an aneurysm measuring >3cm in the thoracic aorta e.g. aortic arch, ascending aorta or descending thoracic aorta. * Patients may also have a AAA * Patients may have had a TEVAR and will have a residual sac * A CT scan of the aorta in the last 3 years |
| Control group | – | Diagnostic Test: Transthoracic ultrasound scanA medically diagnosed Abdominal aortic aneurysm with a CT scan showing no TAA in the last three years. Patients who have also had their AAA repaired will also be eligible for this group. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- All patients recruited will be under the care of the Wessex vascular network at Southampton General Hospital. All patients will be identified using a key work search on CT scans from the last 5 years. This will be carried out by a member of the radiology research team at Southampton General Hospital. Participants who would be eligible for the TAA group would be identified by completing a keyword search of reports on the radiology information system (CRIS). The search will look for any CT scans with the following key words: * Thoracic aorta * Thoracic aortic aneurysm * TAAA * TEVAR * Ectatic Thoracic Aorta Participants who would be eligible for the AAA group with no known TAA would also be identified by completing a keyword search of reports on CRIS. The search will look for any CT scans with the following key words: * Abdominal aorta * Abdominal aortic aneurysm * AAA * EVAR * Ectatic abdominal Aorta
Key inclusion criteria (7 listed)
- For both the Thoracic Aortic Aneurysm (TAA) group and control group, there are no exclusion criteria for gender, ethnicity or socioeconomic status. However, all patients must have a minimum age of 18 years. Patients must have a diagnosis of a Thoracic Aortic Aneurysm or/and Abdominal aortic aneurysm (AAA)
- A medical confirmed TAA defined as an aneurysm measuring >3cm in the thoracic aorta e.g. aortic arch, ascending aorta or descending thoracic aorta.
- Patients may also have a AAA
- Patients may have had a TEVAR and will have a residual sac
- A CT scan of the aorta in the last 3 years
Key exclusion criteria (4 listed)
- • No diagnosed TAA or AAA
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transthoracic ultrasound scanAn ultrasound scan of the thoracic aorta will be performed using an ultrasound machine with 2 MHz phased array transducer. The patient will lay supine on an ultrasound scan couch.The measurements will be taken in B-mode but colour Doppler imaging may be used to identify the thoracic aorta if it is obscured by artefacts. The measurement will be taken inner wall to inner wall and several images will be taken to check reliability. Three different acoustic windows will be used to image the thoracic aorta: 1. Suprasternal window 2. Parasternal long axis window 3. Apical two chamber views Ultrasound assessment will be considered satisfactory when at least two of the three regions of the descending thoracic aorta were visualised, partially satisfactory when a single view was obtained and inconclusive when none of the three windows could be obtained. | Diagnostic test | Control group, Known Thoracic aortic aneurysm (TAA) |
Primary outcome
Can ultrasound detect thoracic aortic aneurysms
Time frame: 6 months
Specificity and sensitivity of ultrasound in detecting thoracic aortic aneurysms
Can thoracic aortic aneurysms be accurately measured using ultrasound
Time frame: 6 months
Specificity and sensitivity of ultrasound in measuring thoracic aortic aneurysms
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2023.
- Individual participant dataSharing planned: No. Access to the final study database will on be allowed for the main researchers of the study and the co-investigators listed on the participant information sheet. The data will be stored on a secure radiology drive on the trust computer system. Archiving will be authorised by the Sponsor following submission of the end of study report. Location and duration of record retention for: * Essential documents: Patient case notes will be stored and maintained according to standard rules and procedures. Pathology results are stored and maintained according to standard procedures. * Study data will be held for minimum of 5 years
Related trials for Thoracic Aortic Aneurysm
Recruiting
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
Recruiting
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Aortic Arch Dissection, Aortic Arch Aneurysm
RecruitingPhase 4
Effect of Remimazolam Versus Propofol Total Intravenous Anesthesia on Intraoperative Hemodynamic Stability in Patients Undergoing Thoracic or Abdominal Endovascular Aortic Repair
Aortic Aneurysm, Thoracoabdominal, Aortic Aneurysm, Abdominal
Not yet recruitingPhase 4
Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery
Aortic Aneurysm of the Proximal Arch, Aortic Aneurysms Arch
Enrolling by invitation
Endovascular Treatment of Thoracic Aortic Disease
Thoracic Aortic Aneurysms, Dissecting, Aneurysm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ben Patterson principal investigator
University Hospital Southampton NHS Foundation Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Thoracic Aortic Aneurysm, run by University Hospital Southampton NHS Foundation Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 13 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Hannah L Davey, MSc (07715935328, hannah.davey@uhs.nhs.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Can ultrasound detect thoracic aortic aneurysms (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2023.